Ligand Pharma (LGND) PT Raised to $245 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright raised its price target on Ligand Pharma (NASDAQ: LGND) to $245.00 (from $239.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
